BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27558929)

  • 1. Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.
    Ozaki S; Kurata M; Kumon Y; Matsumoto S; Tagawa M; Watanabe H; Ohue S; Higaki J; Ohnishi T
    Hypertens Res; 2017 Jan; 40(1):61-66. PubMed ID: 27558929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
    Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
    Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.
    Saber H; Yakoob MY; Shi P; Longstreth WT; Lemaitre RN; Siscovick D; Rexrode KM; Willett WC; Mozaffarian D
    Stroke; 2017 Oct; 48(10):2678-2685. PubMed ID: 28830976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.
    Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J
    Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma thrombin-cleaved osteopontin elevation after carotid artery stenting in symptomatic ischemic stroke patients.
    Kurata M; Okura T; Kumon Y; Tagawa M; Watanabe H; Nakahara T; Miyazaki T; Higaki J; Nose M
    Hypertens Res; 2012 Feb; 35(2):207-12. PubMed ID: 22113358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study.
    Laskowitz DT; Kasner SE; Saver J; Remmel KS; Jauch EC;
    Stroke; 2009 Jan; 40(1):77-85. PubMed ID: 18948614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.
    Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S
    Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biomarker panel: an additional resource in acute stroke evaluation?
    Kimura T; Nishikawa T
    Minerva Anestesiol; 2013 Jul; 79(7):711-2. PubMed ID: 23558768
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
    Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative capacity of biomarkers for acute stroke in the emergency department.
    Glickman SW; Phillips S; Anstrom KJ; Laskowitz DT; Cairns CB
    J Emerg Med; 2011 Sep; 41(3):333-9. PubMed ID: 20417054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS).
    Kuwashiro T; Ago T; Kamouchi M; Matsuo R; Hata J; Kuroda J; Fukuda K; Sugimori H; Fukuhara M; Awano H; Isomura T; Suzuki K; Yasaka M; Okada Y; Kiyohara Y; Kitazono T
    Metabolism; 2014 Sep; 63(9):1093-103. PubMed ID: 24929894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke: comments on data sparsity.
    Ayubi E; Safiri S
    Hypertens Res; 2017 Nov; 40(11):944. PubMed ID: 28855666
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes.
    Ageno W; Finazzi S; Steidl L; Biotti MG; Mera V; Melzi D'Eril G; Venco A
    Arch Intern Med; 2002 Dec 9-23; 162(22):2589-93. PubMed ID: 12456231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimers predict stroke subtype when assessed early.
    Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
    Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study.
    Folsom AR; Gottesman RF; Appiah D; Shahar E; Mosley TH
    Stroke; 2016 Jan; 47(1):18-23. PubMed ID: 26556822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of NT-pro-BNP to Diagnose Cardioembolic Etiology in Patients with Acute Ischemic Stroke.
    Okada Y; Terakawa Y; Murata T; Nakamura K; Shimotake K; Murata H; Ohata K
    Osaka City Med J; 2016 Dec; 62(2):95-102. PubMed ID: 30721584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
    Shio K; Kobayashi H; Asano T; Saito R; Iwadate H; Watanabe H; Sakuma H; Segawa T; Maeda M; Ohira H
    J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100β Protein as a Predictor of Poststroke Functional Outcome: A Prospective Study.
    Branco JP; Oliveira S; Sargento-Freitas J; Santos Costa J; Cordeiro G; Cunha L; Freire Gonçalves A; Pinheiro J
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1890-1896. PubMed ID: 29571758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.
    Montaner J; Mendioroz M; Delgado P; García-Berrocoso T; Giralt D; Merino C; Ribó M; Rosell A; Penalba A; Fernández-Cadenas I; Romero F; Molina C; Alvarez-Sabín J; Hernández-Guillamon M
    J Proteomics; 2012 Aug; 75(15):4758-65. PubMed ID: 22343074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Wang L; Wei C; Deng L; Wang Z; Song M; Xiong Y; Liu M
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1653-1665. PubMed ID: 29598905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.